{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:59:25Z","timestamp":1784033965382,"version":"3.55.0"},"reference-count":35,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["UEG Journal"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Recent studies have suggested a higher recurrence rate of hepatocellular carcinoma (HCC) in patients with a history of HCC and hepatitis C virus (HCV)\u2010associated cirrhosis treated with direct\u2010acting antiviral (DAA) agents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>We conducted a prospective analysis of 24 patients with HCV\u2010associated cirrhosis and treated HCC who received ombitasvir\/paritaprevir\/ritonavir+dasabuvir+ribavirin for 12 weeks. Prior therapies for HCC included resection (9\/24 patients), radiofrequency ablation (RFA) (7\/24) and trans\u2010arterial chemoembolization (TACE) (8\/24). All patients were eligible for treatment if they had no HCC recurrence 6 months after their last procedure. A control group was defined. All patients were followed every 6 months, with dynamic computed tomography and\/or magnetic resonance imaging.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The sustained virological response rate per protocol was 21\/24 (87.5%). The study group included 14 (59%) males, median age 64 years (51\u201377), 50% with associated non\u2010alcoholic steatohepatitis and 24% with Child\u2013Pugh A6 points. HCC recurrence rate\/100 patient\u2010years was lower in the DAA\u2010HCC group versus control: 5.5 versus 24.6% patient\u2010years for the resection+RFA group (<jats:italic>p<\/jats:italic>\u2009=\u20090.044), respectively, and 18.6 versus 72.7% patient\u2010years for TACE group (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). Survival without recurrence was higher in the resection+RFA group (45 compared to 18 months (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001)) and also in the TACE group (44 compared to 11.5 months (<jats:italic>p<\/jats:italic>\u2009=\u20090.002)).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>DAA therapy significantly reduced the recurrence rate of HCC and improved survival without recurrence in patients with treated HCV\u2010associated HCC.<\/jats:p><\/jats:sec>","DOI":"10.1177\/2050640619841254","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T07:12:08Z","timestamp":1553843528000},"page":"699-708","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus\u2010associated cirrhosis after ombitasvir\/paritaprevir\/ritonavir+dasabuvir+ribavirin therapy"],"prefix":"10.1002","volume":"7","author":[{"given":"Carmen M","family":"Preda","sequence":"first","affiliation":[{"name":"Gastroenterology and Hepatology Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Baicus","sequence":"additional","affiliation":[{"name":"Internal Medicine Department Colentina Hospital Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Sandra","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Oproiu","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Manuc","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Constantinescu","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gavrila","sequence":"additional","affiliation":[{"name":"Surgery Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea","family":"Diculescu","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Dumitru","sequence":"additional","affiliation":[{"name":"Radiology Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalin","family":"Vasilescu","sequence":"additional","affiliation":[{"name":"Surgery Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Tieranu","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Elias Emergency Hospital Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doina","family":"Istratescu","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3250-4900","authenticated-orcid":false,"given":"Theodor","family":"Voiosu","sequence":"additional","affiliation":[{"name":"Internal Medicine Department Colentina Hospital Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea","family":"Manuc","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology Department Clinic Fundeni Institute Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,6]]},"reference":[{"key":"e_1_2_11_2_2","unstructured":"World Health Organization.Hepatitis C: Fact sheet http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/. (2017 accessed 23 January 2018)."},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13550"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001606"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0815-7"},{"key":"e_1_2_11_6_2","first-page":"597","article-title":"Drug treatment for chronic hepatitis C infection and cancer risk","volume":"114","author":"W\u00f6rns MA","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_2_11_7_2","first-page":"373","article-title":"The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: A nationwide survey 2006\u2009-\u20092008","volume":"19","author":"Gheorghe L","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"e_1_2_11_8_2","first-page":"51","article-title":"How severe is chronic hepatitis with HCV genotype 1b? A study of 1,220 cases on the waiting list for antiviral therapy in Romania","volume":"20","author":"Pascu O","year":"2011","journal-title":"J Gastrointestin Liver Dis"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000853"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30521"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.01.020"},{"key":"e_1_2_11_12_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.15403\/jgld.2014.1121.263.iac","article-title":"Real-life use of 3 direct-acting antiviral regimen in a large cohort of patients with genotype-1b HCV compensated cirrhosis","volume":"26","author":"Gheorghe L","year":"2017","journal-title":"J Gastrointestin Liver Dis"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000470910"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.045"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.025"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-5033-3"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167934"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179096"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4739-z"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13321"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12726"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.028"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.026"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.008"},{"key":"e_1_2_11_25_2","first-page":"421","article-title":"Occurrence and recurrence of hepatocellular carcinoma after successful direct-acting antiviral therapy for patients with chronic hepatitis C virus infection","volume":"13","author":"Grandhe S","year":"2017","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001004"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13390"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.02.027"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14256"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.06.015"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.016"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.043"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13456"},{"key":"e_1_2_11_34_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jvh.12765","article-title":"A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ITAL-C network study","volume":"25","author":"Barone M","year":"2017","journal-title":"J Viral Hepat"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3168"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13266"}],"container-title":["United European Gastroenterology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/2050640619841254","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1177\/2050640619841254","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/2050640619841254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T11:18:31Z","timestamp":1693739911000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1177\/2050640619841254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1177\/2050640619841254"],"URL":"https:\/\/doi.org\/10.1177\/2050640619841254","archive":["Portico"],"relation":{},"ISSN":["2050-6406","2050-6414"],"issn-type":[{"value":"2050-6406","type":"print"},{"value":"2050-6414","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}